upgrad lh pln help growth
upgrad lh given belief upcom roll-out prefer
lab network posit catalyst stock like inclus
bolster organ growth begin outlook incl seemingli
de-risk fairli conserv guidanc rang street estim look
conserv lh valuat below-histor rel averag make
prefer lab network roll-out juli posit lh
expect roll pln juli lh like main
provid sub-network plan design chang presum zero co-pay
patient physician incent tool empow patient get test done
lowest-cost lab anticip move market share broad provid base
smaller subset low cost high qualiti provid sinc lh combin
share annual lab spend inclus pln drive
meaning market share gain next year boost organ growth
compani analysi point low hang nt revenu opportun
pln player gain modest share bucket would translat ep
boost lh month believ anoth
rel easi tap revenu opportun pln particip begin
pln could conserv see annual lab spend
valuat compel stock
one driver upgrad lh current price-to-earnings discount vs
notabl higher histor averag delta trade price-to-earnings
discount vs notabl wider margin average discount
turn lh trade similarli trade steeper discount vs
index benchmark compar averag discount
nt downsid risk minim management team given earn
paramet recent model consensu ep
comfort upgrad lh quarter-end given view management
team given adequ commentari would make unlik immin
earn shortfal relat market share shift embed guidanc believ
compani incorpor conservat issu lh suggest
quick transit share guidanc assum gradual share ramp
publish above-street ep est believ remain conserv
lh cro drive sotp analysi much stock upsid
one compel argument posit view lh cro covanc
appear gain share detail note dave windley cro space
trade much higher multipl lh current trade sotp analysi
point pt lh
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
summari chang
laboratori corp
pleas see import disclosur inform page report
lh like includ
sub-network provid
introduc call pln
inclus narrow lab network
drive signific market share
next year lh
particip pln come
cost lower rate lh
see net posit contribut
rev ep begin
believ pln easili boost
lh ep
prefer lab network bolster growth
 lh begin
expect lh part pln start materi
benefit begin accru
insur compani expect introduc sub-network
lab provid year way larg insur reduc overal lab spend
improv overal servic level qualiti relat recent post faq
detail compani look start prefer lab network pln lab
part network lh expect includ pln per comment
exhibit among answer question highlight exhibit
network expect becom oper juli believ materi
share shift like benefit lh given beneficiari
make chang util pattern start new benefit year
highlight excerpt pull faq detail insur
provid introduc sub-network within exist network laboratori servic
provid basi qualiti servic well total cost care introduc
sub-network within current provid base presum increment tool would
enabl patient receiv lab servic optim settings/provid
hope consolid market share reduc overal lab cost noteworthi
inclus pln result rate reduct particip provid chosen
lab see posit volum driver without give econom
pleas see import disclosur inform page report
expect pln multi-year volum driver chosen lab provid given
ramp share shift expect occur see nt opportun market
optumcar physician domin popul
tool lever like introduc pln -- zero co-
pay/out-of-pocket patient physician incentives/gain share membership card chang
outlin patient right come site servic option -- certainli drive market
share particip lab lh believ ramp adopt
take year reach full potenti co-pay waiver could deter employ
particip earli could potenti rais near-term benefit cost referr
sourc incent requir appropri structur clinician outreach effort
reason view near-term opportun pln
lab market domin presenc
optumcar physician group refer clinician like particip
new gain-shar arrang employ introduc highlight
exhibit proprietari work show optumcar
follow work analysi medicar advantag enrol
exhibit view adjust plan design quickli within population/
plan offer bulk opportun quickli effect chang market
share shift popul especi given view
sensit plan design changes/cost incent within group beneficiari
compar patient employer-sponsor plan pln effect bring
cost ramp show track record save expect gain
greater traction employ health benefit sponsor provid runway
pln tailwind
pleas see import disclosur inform page report
exhibit enrol popul state
exhibit optumcar physician group state
base proprietari analysi optumcar physician clinic locat estim
member member within counti
pleas see import disclosur inform page report
use assumpt laid exhibit believ annual
revenu opportun member resid counti optumcar
physician estim lh abl gain increment market share
among subset member could result ep growth
believ consensu assum conserv case detail sidebar respect
exhibit revenu opportun member within optumcar counti
ep growth lh
base ep growth
 lh increment
bull ep growth
 lh increment
exhibit potenti ebitda ep accret
exhibit potenti ebitda ep accret
use assumpt laid exhibit believ annual
revenu opportun remain member resid counti outsid
optumcar physician estim lh abl gain
increment market share among subset member could result
 ep growth believ consensu assum conserv case
detail sidebar respect exhibit
growth lh
 lh increment
bull ep growth
 lh increment
pleas see import disclosur inform page report
exhibit revenu opportun member outsid optumcar
exhibit potenti ebitda ep accret
member outsid optumcar counti
exhibit potenti ebitda ep accret
member outisd optumcar counti lh
lt revenu opportun signific reli commerci client adopt
lt revenu opportun result share shift pln lab among
commerci member base pace magnitud volum tailwind reli
speed commerci client adopt nonetheless estim revenu
opportun exce annual exhibit allow lh
benefit organ revenu ebitda growth perspect beyond
pleas see import disclosur inform page report
analysi suggest revenu ep guidanc rang achiev even
base conserv unh/aet contract share shift assumpt
detail exhibit expect gain revenu result
unh/aet contract network chang believ impli
manag guidanc exhibit investor appear skeptic
achiev project actual expect compani deliv revenu
perform line even slightli manag project
evalu reason revenu guidanc particularli relat
market share movement compani labcorp made follow
annual lab spend revenu
revenue per unh/aet req average revenue per req
lose exist aet market share volum ex pennsylvania
lose exist aet market share volum pennsylvania lh
in-network aet exclus lab independ cross
gain increment market share volum ex florida
gain market share volum florida in-network
 exclus lab florida
ebitda contribut margin aet req lost lh
ebitda contribut margin req gain believ
estim conserv take account signific step-up cost relat
increas salesforc ramp-up cost
pleas see import disclosur inform page report
exhibit revenu ebitda impact unh/aet contract chang
confid revenu guidanc lead us believ ebitda project
achiev like conserv
referenc exhibit expect pama repres headwind
revenu essenti off-set expect core commerci
revenu growth outsid network access expansion-rel growth slight
headwind revenu growth reimburs pressur offset slight
volum growth base midpoint revenu guidanc impli
compani expect network access expansion-rel revenu
less expect detail exhibit render revenu
guidanc achiev
expect revenu unh/aet contract network chang
translat ebitda vs impli guidanc exhibit
render ep guidanc achiev
pleas see import disclosur inform page report
exhibit ebitda contribut network access
earn ramp cours year driven volum shift
new cost cut
last coupl week sinc ndr manag receiv numer
inbound investor inquir thought achievability/conservat
manag earn guidanc particularli given ramp quarter quarter
need project manag laid get ep guidanc
year see factor would drive continu improv earn
perform cours year includ
one fewer day explain sequenti soft
roll new cost save program help drive
sequenti improv ebitda low
one work day vs last year result stronger
sequenti increas earn perform vs last year
expect market share gain ramp gradual cours
year even though think opportun see bolu
new volum compani sale effort move low-hang
market share opportun earli year
pleas see import disclosur inform page report
lh market share loss adequ bake manag
guidanc concern potenti miss due volum shift overblown
shown exhibit expect lh lose revenu result
unh/aet contract network chang less estim
impli guidanc exhibit lead us believ lh revenu guidanc
achiev
evalu reason lh revenu guidanc particularli relat
market share movement compani made
annual lab spend lh revenu share
revenue per unh/aet req lh average revenue per req
lh lose exist aet market share volum ex florida
lh lose exist aet market share volum florida in-
network exclus lab florida
lh gain increment aet market share volum ex pennsylvania
lh gain aet market share volum pennsylvania lh in-network
aet exclus lab independ cross
ebitda contribut margin req lost believ
assumpt conserv compani right-siz cost structur reflect
updat geograph mix volum
ebitda contribut margin aet req gain
pleas see import disclosur inform page report
exhibit revenu ebitda impact unh/aet contract chang lh
exhibit revenu impact network access loss lh
lh market share loss translat less ebitda headwind impli
management guidanc suggest conservat current estim
expect loss revenu unh/aet contract network chang
translat loss ebitda exhibit vs loss impli
guidanc exhibit result less headwind earn anticip
allow upsid mid-point lh ep guidanc
pleas see import disclosur inform page report
exhibit ebitda impact network access loss lh
 lh current level
determin right valuat lh look back stock price-to-earnings
multipl period compar averag delta stock rel
 analysi detail exhibit show averag trade
price-to-earnings discount vs lh trade discount vs
market benchmark current level trade price-to-earnings lh trade
price-to-earnings highlight valuat disconnect stock current
level histor trend view guidanc cut compani
announc decemb dent credibl manag team
result discount stock multipl said view
posit catalyst emerg cours year pln announc
proof guidanc conservat form earn track record rebuild
cours year execut capit deploy plan includ share repurchas
acquisit stock see respect valuat multipl firm
get back histor rel level vs
deriv price target lh made assumpt
would see rebound stock price-to-earnings multipl cours year
execut growth cost cut plan deliv earn result restor
pleas see import disclosur inform page report
investor confid respect busi manag team gap vs
 narrow believ stock gradual trade price-to-earnings multipl
appli target multipl above-consensu ep estim
deriv fair valu estim lh respect
addit valuat tabl exhibit sotp analysi also point pt
lh exhibit
pleas see import disclosur inform page report
increment cut given littl chang
lh repres approxim price data point includ
first price adjust relat pama seen mani chang
regul govern composit data contribut chang
definit applic lab clear mani addit hospit
add dataset unlik would see much deviat price
direct rel trend seen two nation player regard price
increas lh receiv contract renew commentari
manag team suggest price stabil commerci insur market
translat stabl price data point lead flat medicar rate
begin
pleas see import disclosur inform page report
labcorp cro busi perform
one driver posit view lh current strength posit outlook
covanc cro busi detail note annual survey say cro outlook
encourag upgrad profil cro client seri part profil cro client seri
part publish recent jefferi cro analyst david windley proprietari survey
pharma manufactur suggest covanc gain market share driven data-
driven approach integr compani core labcorp busi
covance-rel takeaway jefferi cro analyst
sponsor awar covanc iqvia offer
went decemb bu tour one interest comment heard coupl
ceo larg scale depth breadth servic function depth
resourc rel commodit put assumpt test survey
ask particip attribut matter includ servic
resourc depth price specif therapeut expertis other specif
cro best criteria
first took respond either predominantli use larg balanc
mix small larg respond measur familiar
larg platform scale complet unfamiliar complet
familiar respond familiar covanc xceller platform follow
iqvia cro offer rest field parexel iclr
trail behind respond indic roughli equal familiar
allow us obtain context follow-up question prefer
covanc rank ahead larg peer multipl dimens
ask respond identifi top import attribut cro
engag found depth servic attent detail/qu work depth
resourc price specif therapeut expertis import
roughli equal import came custom servic studi start-up insight
data keen understand specif geographi cro brand name respond felt
qualiti less import
covanc came head shoulder peer gener like help
fact respond gener familiar platform
weaker area score well major factor parexel
pleas see import disclosur inform page report
also gener well-regard compris next tier iclr garner
vote among import attribut gener lack depth
servic depth resourc heavili sought fill
bottom rung stack field
import attribut depth servic identifi time attribut
among voter covanc receiv vote cro
perform best measur drop-off parexel follow
receiv vote
attent detail/qu work covanc strong vote
second time vote keep time take
vote tie iclr
domin depth resourc attribut testament global reach scale
emerg market anyon els massiv data lake covanc
somewhat weaker grab vote tie parexel
notabl vote-gett
covanc prove favor price follow iclr
boast abil disrupt industri price model move market
toward fixed-pr contract though current tie categori
respond opinion
covanc shine among sponsor specif therapeut expertis follow
close behind parexel iclr also receiv fair number vote
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
estim valuat
ep amort non-recur item
pleas see import disclosur inform page report
